Notably, in follicular thyroid carcinoma, EphA5 reportedly promotes tumor cell proliferation and suppresses apoptosis via activation of the STAT3 signaling pathway, implicating it in tumor progression and a poor prognosis [11]. Here, STAT3 is linked to neoplasm.